Search results
Results from the WOW.Com Content Network
Note: the activities of the parent companies of many of the companies listed below are not restricted solely to the United Kingdom. For example, AstraZeneca and GlaxoSmithKline , although headquartered in the United Kingdom, have activities in numerous other countries, and Johnson & Johnson and Pfizer are both headquartered in the United States ...
The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. [8] It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, [9] Hoffmann–La Roche ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The Access to Medicine Index ranks 20 of the world's largest originator (research-based) pharmaceutical companies, based on market capitalisation and the relevance of their product portfolios to diseases in the developing world. One unlisted company, Boehringer Ingelheim, is also included since it meets the size and portfolio relevance criteria.
Today's piece will look at the top European pharmaceutical firms, out of which the largest companies are AstraZeneca PLC (NASDAQ:AZN), Novo Nordisk A/S (NYSE:NVO), and Roche Holding AG (SWX:ROG.SW).
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This page was last edited on 17 February 2024, at 21:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.